Literature DB >> 12606332

Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat.

Vishwa Deep Dixit1, Hyunwon Yang, Venkatachalam Udhayakumar, Rajagopala Sridaran.   

Abstract

The interactions between immune-endocrine and reproductive systems are heightened during pregnancy as an adaptive mechanism, and are regulated by a complex array of hormones and cytokines that control the survival of a semiallogeneic conceptus. GnRH can exert direct effects on the immune system via its receptor (GnRH-R) on lymphoid cells. In the present study, we employed in vitro, ex vivo, and in vivo approaches to investigate the role of GnRH in the modulation of T helper cytokines in pregnant rats undergoing termination of pregnancy. Day 8 pregnant rats were infused with a GnRH agonist (GnRH-Ag) for 24 h using an osmotic minipump. Sham control rats were infused with the vehicle, saline. Lymphocytes were isolated from sham and treated rats and polyclonally stimulated with immobilized anti-CD3 antibody. The levels of the signature T helper 1 (Th-1) cytokines (interferon-gamma [IFN-gamma] and interleukin-2 [IL-2]) and Th-2 cytokines (IL-4 and IL-10) were measured in culture supernatants. Using immunoflourescence confocal microscopy, we demonstrated for the first time the spatial localization of GnRH-R protein on the surface of lymphocytes. We observed a marked increase in IFN-gamma and inhibition of IL-4 production from lymphocytes of pregnant rats treated in vitro with different doses of GnRH-Ag. Further, the responsiveness of lymphocytes to produce IFN-gamma was markedly increased in cells cultured ex vivo from GnRH-Ag infused rats, whereas the capacity of lymphocytes to produce IL-4 was significantly inhibited. In addition, GnRH-Ag infusion in pregnant rats induced a shift toward Th-1 cytokines in the serum. We did not observe any significant difference in IL-2 and IL-10 production in response to GnRH-Ag. Our results suggest an additional function for GnRH as a Th-1 inducer and Th-2 inhibitor. GnRH can thus skew the cytokine balance to predominantly Th-1 type in pregnancy, leading to the termination of pregnancy in rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606332     DOI: 10.1095/biolreprod.102.012211

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  11 in total

Review 1.  A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients.

Authors:  C Jin; Y Fan; Y Meng; C Shen; Y Wang; S Hu; C Cui; T Xu; W Yu; J Jin
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-09-06       Impact factor: 5.554

Review 2.  Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.

Authors:  Timothy N Clinton; Solomon L Woldu; Ganesh V Raj
Journal:  Expert Opin Pharmacother       Date:  2017-05-19       Impact factor: 3.889

3.  Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.

Authors:  Andrew V Kossenkov; Anil Vachani; Celia Chang; Calen Nichols; Shere Billouin; Wenhwai Horng; William N Rom; Steven M Albelda; Michael K Showe; Louise C Showe
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 4.  Approach to Androgen Deprivation in the Prostate Cancer Patient with Pre-existing Cardiovascular Disease.

Authors:  Alyssa K Greiman; Thomas E Keane
Journal:  Curr Urol Rep       Date:  2017-06       Impact factor: 3.092

5.  Gut Barrier Dysfunction and Type 2 Immunity: Implications for Compulsive Behavior.

Authors:  Christopher T Fields; Benoit Chassaing; Geert J de Vries
Journal:  Med Hypotheses       Date:  2022-02-14       Impact factor: 4.411

6.  Increased testosterone and proinflammatory cytokines in patients with polycystic ovary syndrome correlate with elevated GnRH receptor autoantibody activity assessed by a fluorescence resonance energy transfer-based bioassay.

Authors:  Hongliang Li; Yankai Guo; Jielin Deng; Hayley Fischer; Elizabeth A Weedin; Heather R Burks; LaTasha B Craig; Xichun Yu
Journal:  Endocrine       Date:  2021-05-20       Impact factor: 3.925

7.  Differences in Hypercholesterolemia and Atherogenesis Induced by Common Androgen Deprivation Therapies in Male Mice.

Authors:  Christian Bo Poulsen; Martin Bødtker Mortensen; Wolfgang Koechling; Charlotte Brandt Sørensen; Jacob Fog Bentzon
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

Review 8.  Cardiovascular Toxicities of Androgen Deprivation Therapy.

Authors:  Azariyas A Challa; Adam Christopher Calaway; Jennifer Cullen; Jorge Garcia; Nihar Desai; Neal L Weintraub; Anita Deswal; Shelby Kutty; Ajay Vallakati; Daniel Addison; Ragavendra Baliga; Courtney M Campbell; Avirup Guha
Journal:  Curr Treat Options Oncol       Date:  2021-04-17

9.  Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.

Authors:  Sven Saussez; Barbara Laumbacher; Gilbert Chantrain; Alexandra Rodriguez; Songhai Gu; Rudolf Wank; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-07-17       Impact factor: 3.850

10.  Hypothalamic neurohormones and immune responses.

Authors:  J Luis Quintanar; Irene Guzmán-Soto
Journal:  Front Integr Neurosci       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.